IL163305A - Azacycloalkyl glucosaminide phosphate as immunoeffector compounds and pharmaceutical compositions for propylactic and therapeutic treatment of infectious and therapeutic treatment of infectious and other diseases comprising the same - Google Patents
Azacycloalkyl glucosaminide phosphate as immunoeffector compounds and pharmaceutical compositions for propylactic and therapeutic treatment of infectious and therapeutic treatment of infectious and other diseases comprising the sameInfo
- Publication number
- IL163305A IL163305A IL16330502A IL16330502A IL163305A IL 163305 A IL163305 A IL 163305A IL 16330502 A IL16330502 A IL 16330502A IL 16330502 A IL16330502 A IL 16330502A IL 163305 A IL163305 A IL 163305A
- Authority
- IL
- Israel
- Prior art keywords
- infectious
- therapeutic treatment
- propylactic
- azacycloalkyl
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2002/003581 WO2003066065A1 (en) | 2002-02-04 | 2002-02-04 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL163305A true IL163305A (en) | 2010-10-31 |
Family
ID=27732076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16330502A IL163305A (en) | 2002-02-04 | 2002-02-04 | Azacycloalkyl glucosaminide phosphate as immunoeffector compounds and pharmaceutical compositions for propylactic and therapeutic treatment of infectious and therapeutic treatment of infectious and other diseases comprising the same |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1482955B1 (zh) |
| JP (1) | JP2005523902A (zh) |
| KR (1) | KR100858947B1 (zh) |
| CN (2) | CN1622812A (zh) |
| AU (1) | AU2002255513B2 (zh) |
| BR (1) | BR0215583A (zh) |
| CA (1) | CA2474402C (zh) |
| CZ (1) | CZ2004861A3 (zh) |
| ES (1) | ES2453903T3 (zh) |
| HU (1) | HUP0402570A3 (zh) |
| IL (1) | IL163305A (zh) |
| MX (1) | MXPA04007491A (zh) |
| NO (1) | NO20043693L (zh) |
| NZ (1) | NZ534592A (zh) |
| WO (1) | WO2003066065A1 (zh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1301134C (zh) * | 2002-02-04 | 2007-02-21 | 科里克萨有限公司 | 新的免疫效应化合物 |
| US6911434B2 (en) | 2002-02-04 | 2005-06-28 | Corixa Corporation | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
| WO2006093352A1 (ja) * | 2005-03-04 | 2006-09-08 | Riken | 環状構造を有する化合物及びその用途 |
| EP2437753B1 (en) * | 2009-06-05 | 2016-08-31 | Infectious Disease Research Institute | Synthetic glucopyranosyl lipid adjuvants and vaccine compositions containing them |
| GB201101331D0 (en) | 2011-01-26 | 2011-03-09 | Glaxosmithkline Biolog Sa | Compositions and uses |
| GB201113570D0 (en) | 2011-08-05 | 2011-09-21 | Glaxosmithkline Biolog Sa | Vaccine |
| AU2020318680A1 (en) | 2019-07-21 | 2022-02-17 | Glaxosmithkline Biologicals Sa | Therapeutic viral vaccine |
| WO2021245611A1 (en) | 2020-06-05 | 2021-12-09 | Glaxosmithkline Biologicals Sa | Modified betacoronavirus spike proteins |
| EP4032547A1 (en) | 2021-01-20 | 2022-07-27 | GlaxoSmithKline Biologicals S.A. | Hsv1 fce derived fragements for the treatment of hsv |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| CN1606446A (zh) | 2000-05-19 | 2005-04-13 | 科里克萨有限公司 | 用单糖和二糖类化合物预防和治疗传染病和其他疾病的方法 |
| WO2002012258A1 (en) | 2000-08-04 | 2002-02-14 | Corixa Corporation | New immunoeffector compounds |
| CN1301134C (zh) * | 2002-02-04 | 2007-02-21 | 科里克萨有限公司 | 新的免疫效应化合物 |
-
2002
- 2002-02-04 CA CA2474402A patent/CA2474402C/en not_active Expired - Lifetime
- 2002-02-04 MX MXPA04007491A patent/MXPA04007491A/es active IP Right Grant
- 2002-02-04 BR BR0215583-4A patent/BR0215583A/pt not_active Application Discontinuation
- 2002-02-04 HU HU0402570A patent/HUP0402570A3/hu unknown
- 2002-02-04 NZ NZ534592A patent/NZ534592A/en not_active IP Right Cessation
- 2002-02-04 ES ES02724914.3T patent/ES2453903T3/es not_active Expired - Lifetime
- 2002-02-04 EP EP02724914.3A patent/EP1482955B1/en not_active Expired - Lifetime
- 2002-02-04 CN CNA028284356A patent/CN1622812A/zh active Pending
- 2002-02-04 WO PCT/US2002/003581 patent/WO2003066065A1/en active Application Filing
- 2002-02-04 JP JP2003565489A patent/JP2005523902A/ja not_active Withdrawn
- 2002-02-04 IL IL16330502A patent/IL163305A/xx unknown
- 2002-02-04 CZ CZ2004861A patent/CZ2004861A3/cs unknown
- 2002-02-04 KR KR1020047011969A patent/KR100858947B1/ko active IP Right Grant
- 2002-02-04 CN CN200710161297XA patent/CN101138566B/zh not_active Expired - Lifetime
- 2002-02-04 AU AU2002255513A patent/AU2002255513B2/en not_active Expired
-
2004
- 2004-09-03 NO NO20043693A patent/NO20043693L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ534592A (en) | 2006-06-30 |
| AU2002255513B2 (en) | 2008-03-06 |
| CA2474402A1 (en) | 2003-08-14 |
| MXPA04007491A (es) | 2004-11-10 |
| EP1482955A1 (en) | 2004-12-08 |
| CA2474402C (en) | 2012-09-11 |
| AU2002255513A1 (en) | 2003-09-02 |
| HUP0402570A3 (en) | 2006-02-28 |
| CN101138566B (zh) | 2012-05-23 |
| BR0215583A (pt) | 2004-12-21 |
| CN101138566A (zh) | 2008-03-12 |
| JP2005523902A (ja) | 2005-08-11 |
| KR100858947B1 (ko) | 2008-09-17 |
| ES2453903T3 (es) | 2014-04-08 |
| EP1482955B1 (en) | 2013-12-25 |
| KR20040081174A (ko) | 2004-09-20 |
| CZ2004861A3 (cs) | 2004-12-15 |
| NO20043693L (no) | 2004-09-03 |
| CN1622812A (zh) | 2005-06-01 |
| WO2003066065A1 (en) | 2003-08-14 |
| EP1482955A4 (en) | 2008-08-06 |
| HUP0402570A2 (hu) | 2005-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0200493A2 (en) | Pharmaceutical compositions comprising sulphonyl-amino-carbonyl derivatives for the treatment of nuclear factor-kappa b mediated diseases | |
| IL230815A0 (en) | Dictopiperazine compounds and pharmaceutical preparations containing them for the treatment of T-cell mediated diseases | |
| HUP0401514A3 (en) | Pharmaceutical compositions for the treatment of asthma | |
| AU2002329990A1 (en) | Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith | |
| NO324227B1 (no) | Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer | |
| HUP0301815A3 (en) | Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment | |
| HUP0203437A3 (en) | Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases | |
| IL169338A0 (en) | Therapeutic formulations for the treatment of beta-amyloid related diseases | |
| IL157656A (en) | Metalloproteinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of diseases mediated by metalloproteinase enzymes | |
| HUP0302726A3 (en) | Methods of administering pharmaceutical composition containing epothilone analogs for the treatment of cancer and of preparation the same | |
| ZA200707934B (en) | Thereapeutic formulations for the treatment of beta-amyloid related diseases | |
| EP1575480A4 (en) | COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO THE IMMUNE SYSTEM | |
| EP1572116A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES | |
| IL161070A0 (en) | Compositions for the treatment of infectious diseases | |
| EP1648474A4 (en) | PROCESS AND PHARMACEUTICAL COMPOSITIONS FOR WOUND HEALING | |
| HK1100812A1 (en) | Composition for the prophylaxis/treatment of hbv infections and hbv- mediated diseases | |
| IL173148A0 (en) | Methods and pharmaceutical compositions for healing wounds | |
| DE60218375D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen | |
| IL163305A (en) | Azacycloalkyl glucosaminide phosphate as immunoeffector compounds and pharmaceutical compositions for propylactic and therapeutic treatment of infectious and therapeutic treatment of infectious and other diseases comprising the same | |
| HUP0401392A3 (en) | Use of composition comprising anti-hla-antibody for treatment of diseases involving prolierative immune response | |
| TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same | |
| AU2002322082A1 (en) | Pharmaceutical composition for the treatment of viral infection | |
| RS60604A (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
| EP1472273A4 (en) | COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISEASES | |
| HUP0400925A3 (en) | Azolycarbynol derivatives of aryl (or heteroaryl) for producing pharmaceutical compositions for the treatment of respiratory diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed |